Head and neck cancer reirradiation with interstitial high‐dose‐rate brachytherapy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Head and Neck

• Publication date

  2018-07-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/hed.25137PMID 29573121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.

  2017cited by this paper
• Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.

  2017cited by this paper
• Head and neck second primary cancer rates in the human papillomavirus era: A population‐based analysis

  2016cited by this paper
• Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.

  2016cited by this paper
• Predictors of severe long-term toxicity after re-irradiation for head and neck cancer.

  2016cited by this paper
• Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.

  2016cited by this paper
• Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long‐term follow‐up of a large series

  2015cited by this paper
• Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy

  2015cited by this paper
• Surgical Salvage of Recurrent Cancer of the Head and Neck

  2014cited by this paper
• Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.

  2014cited by this paper
• Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

  2014cited by this paper
• Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.

  2013cited by this paper
• High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers.

  2012cited by this paper
• Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.

  2011cited by this paper
• Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

  2011cited by this paper
• Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility.

  2011cited by this paper
• Fractionated Stereotactic Body Radiation Therapy in the Treatment of Previously-Irradiated Recurrent Head and Neck Carcinoma: Updated Report of the University of Pittsburgh Experience

  2009cited by this paper
• IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

  2009cited by this paper
• Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.

  2007cited by this paper
• High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.

  2007cited by this paper
• Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.

  2005cited by this paper

• Efficacy and tolerability of probiotics, prebiotics, and symbiotics consumption on oral complications of patients with thyroid and head and neck cancers: a systematic review and meta-analysis

  2025cites this paper
• Outcomes and dosimetric analysis of reirradiation of oral cavity and oropharyngeal cancers with high-dose-rate brachytherapy.

  2025cites this paper
• Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer

  2024cites this paper
• A novel multifunctional radioprotective strategy using P7C3 as a countermeasure against ionizing radiation-induced bone loss

  2023cites this paper
• Advancements of radiotherapy for recurrent head and neck cancer in modern era

  2023cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence

  2022cites this paper
• Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.

  2022cites this paper
• Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue.

  2022cites this paper
• Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review

  2022cites this paper
• Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients

  2021cites this paper
• Status of Treatment and Prophylaxis for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer

  2021cites this paper
• A national surveillance study of the current status of reirradiation using brachytherapy in Japan.

  2020cites this paper
• Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma.

  2020cites this paper
• Feasibility of interstitial stepping-source electronic brachytherapy to locally inoperable tumors

  2020cites this paper
• Brachytherapy of tongue carcinoma in a patient with difficult airway: anesthetic considerations

  2018cites this paper